{
  "Version": 76,
  "Individuals": [
    {
      "Name": "European (P-gp modified, CYP3A4 36 h)",
      "Seed": 17189110,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Parameters": [
        {
          "Path": "Organism|Liver|EHC continuous fraction",
          "Value": 1.0,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          },
          "Parameters": [
            {
              "Name": "t1/2 (liver)",
              "Value": 36.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "AADAC",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "BloodCells",
              "Value": 3.9102564103E-05
            },
            {
              "Name": "Plasma",
              "Value": 3.9102564103E-05
            },
            {
              "Name": "Bone",
              "Value": 4.8717948718E-05
            },
            {
              "Name": "Brain",
              "Value": 3.9743589744E-05
            },
            {
              "Name": "Gonads",
              "Value": 0.0011923076923
            },
            {
              "Name": "Heart",
              "Value": 0.0026602564103
            },
            {
              "Name": "Kidney",
              "Value": 5.7051282051E-05
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.0269230769
            },
            {
              "Name": "Muscle",
              "Value": 0.00020833333333
            },
            {
              "Name": "Pancreas",
              "Value": 0.1474358974
            },
            {
              "Name": "Spleen",
              "Value": 0.00037115384615
            },
            {
              "Name": "Stomach",
              "Value": 0.0775641026
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.2544871795
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.00010384615385
            },
            {
              "Name": "Duodenum",
              "Value": 0.2544871795
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.2544871795
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.2544871795
            },
            {
              "Name": "UpperIleum",
              "Value": 0.2544871795
            },
            {
              "Name": "LowerIleum",
              "Value": 0.2544871795
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.00010384615385
            }
          ]
        },
        {
          "Name": "ABCB1",
          "Type": "Transporter",
          "TransportType": "Efflux",
          "Expression": [
            {
              "Name": "Bone",
              "MembraneLocation": "Basolateral",
              "Value": 0.0341950646
            },
            {
              "Name": "Brain",
              "MembraneLocation": "BloodBrainBarrier",
              "Value": 0.1072855464
            },
            {
              "Name": "Gonads",
              "MembraneLocation": "Basolateral",
              "Value": 0.024559342
            },
            {
              "Name": "Heart",
              "MembraneLocation": "Basolateral",
              "Value": 0.059106933
            },
            {
              "Name": "Kidney",
              "MembraneLocation": "Apical",
              "Value": 1.0
            },
            {
              "Name": "Periportal",
              "MembraneLocation": "Apical",
              "Value": 0.2702702703
            },
            {
              "Name": "Pericentral",
              "MembraneLocation": "Apical",
              "Value": 0.2702702703
            },
            {
              "Name": "Lung",
              "MembraneLocation": "Basolateral",
              "Value": 0.0927144536
            },
            {
              "Name": "Muscle",
              "MembraneLocation": "Basolateral",
              "Value": 0.0180963572
            },
            {
              "Name": "Pancreas",
              "MembraneLocation": "Basolateral",
              "Value": 0.0200940071
            },
            {
              "Name": "Spleen",
              "MembraneLocation": "Basolateral",
              "Value": 0.1047003525
            },
            {
              "Name": "Stomach",
              "MembraneLocation": "Basolateral",
              "Value": 0.0367802585
            },
            {
              "Name": "SmallIntestine",
              "MembraneLocation": "Basolateral",
              "Value": 0.3960047004
            },
            {
              "Name": "LargeIntestine",
              "MembraneLocation": "Basolateral",
              "Value": 0.1562867215
            },
            {
              "Name": "Duodenum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "UpperJejunum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "LowerJejunum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "UpperIleum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "LowerIleum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "ColonAscendens",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonTransversum",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonDescendens",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonSigmoid",
              "MembraneLocation": "Apical",
              "Value": 0.56
            }
          ],
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 1.41,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "OATP1B1",
          "Type": "Transporter",
          "TransportType": "Influx",
          "Expression": [
            {
              "Name": "Brain",
              "MembraneLocation": "BloodBrainBarrier",
              "Value": 0.00014166666667
            },
            {
              "Name": "Gonads",
              "MembraneLocation": "Basolateral",
              "Value": 0.0141666667
            },
            {
              "Name": "Heart",
              "MembraneLocation": "Basolateral",
              "Value": 0.0008253968254
            },
            {
              "Name": "Periportal",
              "MembraneLocation": "Basolateral",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "MembraneLocation": "Basolateral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "MembraneLocation": "Basolateral",
              "Value": 4.0079365079E-05
            },
            {
              "Name": "Muscle",
              "MembraneLocation": "Basolateral",
              "Value": 0.00064682539683
            }
          ]
        },
        {
          "Name": "ATP1A2",
          "Type": "OtherProtein",
          "MembraneLocation": "Apical",
          "TissueLocation": "ExtracellularMembrane",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Bone",
              "Value": 0.0062154033171
            },
            {
              "Name": "Brain",
              "Value": 1.0
            },
            {
              "Name": "Gonads",
              "Value": 0.0508741242
            },
            {
              "Name": "Heart",
              "Value": 0.3179118843
            },
            {
              "Name": "Kidney",
              "Value": 0.0158938619
            },
            {
              "Name": "Periportal",
              "Value": 0.0223784807
            },
            {
              "Name": "Pericentral",
              "Value": 0.0223784807
            },
            {
              "Name": "Lung",
              "Value": 0.0272345453
            },
            {
              "Name": "Muscle",
              "Value": 0.7034193524
            },
            {
              "Name": "Pancreas",
              "Value": 0.0073903254795
            },
            {
              "Name": "Skin",
              "Value": 0.0389467988
            },
            {
              "Name": "Spleen",
              "Value": 0.0103243118
            },
            {
              "Name": "Stomach",
              "Value": 0.0309435884
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0501579923
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.0786998764
            },
            {
              "Name": "Duodenum",
              "Value": 0.0501579923
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0501579923
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0501579923
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0501579923
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0501579923
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.0786998764
            }
          ],
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 0.47661714,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "UGT1A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            }
          ],
          "Ontogeny": {
            "Name": "UGT1A4"
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 2.32,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "GABRG2",
          "Type": "OtherProtein",
          "MembraneLocation": "Apical",
          "TissueLocation": "ExtracellularMembrane",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 1.0
            }
          ],
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 1.0877710492,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ]
    }
  ],
  "Compounds": [
    {
      "Name": "Rifampicin",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.5,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "Name": "DrugBank logP",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.7,
              "Unit": "Log Units"
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Templeton 2011",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 17.0,
              "Unit": "%",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Other",
                "Description": "Templeton 2011 (equilibrium dialysis)"
              }
            }
          ]
        },
        {
          "Name": "Baneyx 2013",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 16.0,
              "Unit": "%"
            }
          ]
        },
        {
          "Name": "Boman 1974",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 11.0,
              "Unit": "%"
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Aqueous solubility",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 2800.0,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Database",
                "Description": "DrugBank"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Database",
                "Description": "DrugBank"
              }
            }
          ]
        },
        {
          "Name": "FaSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 450.0,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 6.5
            }
          ]
        },
        {
          "Name": "FeSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 1600.0,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 5.0
            }
          ]
        },
        {
          "Name": "Optimized",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 1211.88,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 7.0
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 1.24E-05,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 7.9,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Type": "Acid",
          "Pka": 1.7,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationSpecific_MM",
          "DataSource": "Nakajima 2011",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "Enzyme concentration",
              "Value": 1.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 6.5,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 195.1,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 9.865,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Collett 2004",
          "Molecule": "ABCB1",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 60.0,
              "Unit": "nmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 2.87,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 55.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 0.6088,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Tirona 2003",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 109.6,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 0.372,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 1.5,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 7.796,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "GFR",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 1.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Kajosaari 2005",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 18.5,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Kajosaari et al. 2005"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Reitman 2011",
          "Molecule": "ABCB1",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 169.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Reitman 2011 (IC50 = Ki (169 µM / (1+ (0.1 µM / 177 µM) )"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Templeton 2011",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            },
            {
              "Name": "Emax",
              "Value": 9.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Greiner 1999",
          "Molecule": "ABCB1",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 2.5,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Greiner et al. 1999"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Dixit 2007",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.383,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Assumed",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.985,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 822.94,
          "Unit": "g/mol"
        },
        {
          "Name": "Enable supersaturation",
          "Value": 0.0
        }
      ]
    },
    {
      "Name": "Midazolam",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.8972038771,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "Name": "LogP (Simcyp)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.53,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Simcyp"
              }
            }
          ]
        },
        {
          "Name": "LogP (experimental) (Dagenais)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.0,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Dagenais 2009"
              }
            }
          ]
        },
        {
          "Name": "LogP (GastroPlus)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.37,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "GastroPlus"
              }
            }
          ]
        },
        {
          "Name": "LogP (experimental) (Rodgers & Rowland)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.1,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Rodgers and Rowland"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Simcyp",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.032,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Simcyp"
              }
            }
          ]
        },
        {
          "Name": "Gertz et al. 2010",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.031,
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "Name": "Lown et al. 1995",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.022,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Lown et al. 1995"
              }
            }
          ]
        },
        {
          "Name": "Björkman et al. 2001 (men)",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.016
            }
          ]
        },
        {
          "Name": "Björkman et al. 2001 (women)",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.02
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Aqueous solubility",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 0.13,
              "Unit": "mg/ml",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            }
          ]
        },
        {
          "Name": "FaSSIF",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 0.049,
              "Unit": "mg/ml",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 6.5,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            }
          ]
        },
        {
          "Name": "FeSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 0.09,
              "Unit": "mg/ml",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 0.00015549970673,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 6.2
        },
        {
          "Type": "Acid",
          "Pka": 10.95
        }
      ],
      "Processes": [
        {
          "InternalName": "SpecificBinding",
          "DataSource": "Buhr 1997",
          "Molecule": "GABRG2",
          "Parameters": [
            {
              "Name": "koff",
              "Value": 1.0,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "Kd",
              "Value": 1.8,
              "Unit": "nmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Patki et al. 2003",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 0.18,
              "Unit": "nmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 3.9,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "rCYP450_MM",
          "DataSource": "Simcyp",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax/recombinant enzyme",
              "Value": 2.16,
              "Unit": "pmol/min/pmol rec. enzyme"
            },
            {
              "Name": "Km",
              "Value": 2.16,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Optimized",
          "Molecule": "UGT1A4",
          "Metabolite": "Midazolam-N-glucuronide",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 276.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 58.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Achour 2014"
              }
            },
            {
              "Name": "Km",
              "Value": 37.8,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "kcat",
              "Value": 3.5911771641,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "Optimized",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 0.6401025724,
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Optimized",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 850.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 4.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "kcat",
              "Value": 8.7607941215,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "InternalName": "rCYP450_MM",
          "DataSource": "Galentin et al. 2004",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax/recombinant enzyme",
              "Value": 1.96,
              "Unit": "pmol/min/pmol rec. enzyme"
            },
            {
              "Name": "Km",
              "Value": 2.69,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Ito et al. 2003",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 4.41,
              "Unit": "nmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 3.8,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "GastroPlus",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 850.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 4.0,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Klieber et al. 2008",
          "Molecule": "UGT1A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 276.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 58.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Achour 2014"
              }
            },
            {
              "Name": "Km",
              "Value": 37.8,
              "Unit": "µmol/l"
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Cl",
          "Value": 1.0
        },
        {
          "Name": "F",
          "Value": 1.0
        },
        {
          "Name": "Molecular weight",
          "Value": 325.78,
          "Unit": "g/mol"
        },
        {
          "Name": "Enable supersaturation",
          "Value": 0.0
        }
      ]
    }
  ],
  "Formulations": [
    {
      "Name": "Tablet (Dormicum)",
      "FormulationType": "Formulation_Tablet_Weibull",
      "Parameters": [
        {
          "Name": "Dissolution time (50% dissolved)",
          "Value": 0.0107481462,
          "Unit": "min",
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'PI Tablet 7.5 mg' on 2019-04-09 16:30"
          }
        },
        {
          "Name": "Lag time",
          "Value": 0.0,
          "Unit": "min"
        },
        {
          "Name": "Dissolution shape",
          "Value": 4.3802943225,
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'PI Tablet 7.5 mg' on 2019-04-09 16:30"
          }
        },
        {
          "Name": "Use as suspension",
          "Value": 1.0
        }
      ]
    },
    {
      "Name": "Oral solution",
      "FormulationType": "Formulation_Dissolved"
    }
  ],
  "Protocols": [
    {
      "Name": "Backman 1996 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1996 - Midazolam - 15 mg (with Perpetrator)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 113.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1996 - Midazolam - 15 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1998 - Midazolam - 15 mg (Phase I Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 113.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 185.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1998 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Rifampicin - 600 mg MD OD 8 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 8.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 166.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator) 2",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 166.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Midazolam - 0.075 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Midazolam - 7.5 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 89.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 113.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Rifampicin - 450 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 450.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - po 4 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 4.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - po 6 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 6.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Rifampicin - 600 mg MD OD 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2006 - Midazolam - po 8 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2006 - Midazolam - po 8 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 146.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2006 - Rifampicin - 300 mg MD BID 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2008 - Midazolam - po 8 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2008 - Midazolam - po 8 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 146.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2008 - Rifampicin - 300 mg MD BID 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Midazolam - po 3 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 104.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 128.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - iv 2 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - po 7.5 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - iv 2 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - po 7.5 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Rifampicin - 600 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 106.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 648.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 816.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 3",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 984.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 4",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 1320.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Reitman 2011 - Rifampicin - 600 mg MD OD 28 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 28.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Szalat 2007 - Rifampicin - 600 mg MD OD 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 108.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 5.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 10.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 25.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 75.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Midazolam - po 3 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 1997 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 1997 - Midazolam - iv 1 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    }
  ],
  "Simulations": [
    {
      "Name": "DDI Control - Midazolam - Backman 1996",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1996 - Midazolam - 15 mg (Control)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1996 - Midazolam - 15 mg (Control)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Backman 1996-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Backman 1996|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Control - Backmann 1996\n2019-04-16 13:13"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 209.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)|Tablet (Dormicum)|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Backman 1998 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1998-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1998|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1998-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1998|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Backman 1998\n2019-05-07 19:20"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Backman 1998",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1998 - Midazolam - 15 mg (Phase I Control)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1998 - Midazolam - 15 mg (Phase I Control)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Backman 1998-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Backman 1998|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Control - Backmann 1998\n2019-04-16 13:26"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 137.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1996 - Midazolam - 15 mg (with Perpetrator)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1996 - Midazolam - 15 mg (with Perpetrator)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Backman 1996 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1996-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1996|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1996-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1996|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Backmann 1996\n2019-04-16 13:09"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 190.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Chung 2006 - Rifampicin - 600 mg MD OD 8 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Chung 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Chung 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Chung 2006-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Chung 2006|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Chung 2006\n2019-04-16 18:28"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Chung 2006",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Chung 2006 - Midazolam - 0.075 mg/kg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Chung 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Chung 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 137.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Rifampicin - 450 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Eap 2004-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Eap 2004|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Eap 2004-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Eap 2004|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Eap 2004\n2019-04-17 11:05"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Eap 2004 - Midazolam - 0.075 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Midazolam - 0.075 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Eap 2004 (0.075 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Eap 2004 (0.075 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Eap 2004 - Midazolam - 7.5 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Midazolam - 7.5 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Eap 2004 (7.5 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Eap 2004 (7.5 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - iv 0.05 mg/kg (with Rifampicin)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Rifampicin - 600 mg MD OD 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)\n2019-04-17 11:16"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - po 6 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Whole Blood (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - po 6 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Rifampicin - 600 mg MD OD 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gorski 2003 (iv)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - iv 0.05 mg/kg (Control)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gorski 2003 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gorski 2003 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gorski 2003 (po)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - po 4 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - po 4 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gorski 2003 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gorski 2003 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gurley 2006",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2006 - Midazolam - po 8 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2006 - Midazolam - po 8 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gurley 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gurley 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gurley 2008",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2008 - Midazolam - po 8 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2008 - Midazolam - po 8 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gurley 2008-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gurley 2008|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 170.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2006 - Midazolam - po 8 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2006 - Midazolam - po 8 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2006 - Rifampicin - 300 mg MD BID 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 170.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2008 - Midazolam - po 8 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2008 - Midazolam - po 8 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2008 - Rifampicin - 300 mg MD BID 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Gurley 2006\n2019-04-17 11:23"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 152.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2004 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 93.62808,
              "Max": 145.4821,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.07266742,
              "Max": 15175.4,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Kharasch 2004\n2019-04-17 11:33"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2004 (iv)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2004 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2004 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2004 (po)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2004 - Midazolam - po 3 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Midazolam - po 3 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2004 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2004 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Link 2008 - Midazolam - po 7.5 mg (with Rifampicin)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - po 7.5 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Rifampicin - 600 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Link 2008 (po)\n2019-04-17 12:21"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - iv 2 mg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Rifampicin - 600 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)\n2019-04-17 12:20"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Link 2008 (po)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Link 2008 - Midazolam - po 7.5 mg (Control)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - po 7.5 mg (Control)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Link 2008 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Link 2008 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Link 2008 (iv)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - iv 2 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Link 2008 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Link 2008 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 128.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Phimmasone 2001\n2019-04-17 12:24"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Phimmasone 2001",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Phimmasone 2001-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Phimmasone 2001|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 1344.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_15|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_16|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_17|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_18|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_19|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_20|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_21|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_22|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_23|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_24|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_25|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_26|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_27|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_28|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Reitman 2011 - Rifampicin - 600 mg MD OD 28 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Reitman 2011\n2019-04-17 12:33"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Szalat 2007 - Midazolam - iv 0.05 mg/kg (with Rifampicin)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Szalat 2007 - Rifampicin - 600 mg MD OD 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Szalat 2007\n2019-04-17 12:40"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Szalat 2007",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Szalat 2007 - Midazolam - iv 0.05 mg/kg (Control)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Szalat 2007-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Szalat 2007|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)\n2019-04-17 12:45"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2011 (iv)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2011 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2011 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2011 (po)",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - po 3 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - po 3 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2011 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2011 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 1997",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 1997 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 1997-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 1997|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
      "Model": "4Comp",
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 152.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 1997 - Midazolam - iv 1 mg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "ABCB1-Collett 2004",
              "MoleculeName": "ABCB1"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Kharasch 1997\n2019-05-03 16:57"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Reitman 2011",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "ABCB1-Greiner 1999",
          "MoleculeName": "ABCB1",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    }
  ],
  "SimulationClassifications": [
    {
      "Name": "Backman 1996",
      "Classifiables": [
        "DDI Control - Midazolam - Backman 1996",
        "DDI Treatment - Rifampicin/Midazolam - Backman 1996"
      ]
    },
    {
      "Name": "Backman 1998",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
        "DDI Control - Midazolam - Backman 1998"
      ]
    },
    {
      "Name": "Chung 2006",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
        "DDI Control - Midazolam - Chung 2006"
      ]
    },
    {
      "Name": "Eap 2004",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
        "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
        "DDI Control - Midazolam - Eap 2004 (7.5 mg)"
      ]
    },
    {
      "Name": "Gorski 2003",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
        "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
        "DDI Control - Midazolam - Gorski 2003 (iv)",
        "DDI Control - Midazolam - Gorski 2003 (po)"
      ]
    },
    {
      "Name": "Gurley 2006",
      "Classifiables": [
        "DDI Control - Midazolam - Gurley 2006",
        "DDI Treatment - Rifampicin/Midazolam - Gurley 2006"
      ]
    },
    {
      "Name": "Gurley 2008",
      "Classifiables": [
        "DDI Control - Midazolam - Gurley 2008",
        "DDI Treatment - Rifampicin/Midazolam - Gurley 2008"
      ]
    },
    {
      "Name": "Kharasch 2004",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
        "DDI Control - Midazolam - Kharasch 2004 (iv)",
        "DDI Control - Midazolam - Kharasch 2004 (po)"
      ]
    },
    {
      "Name": "Link 2008",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
        "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
        "DDI Control - Midazolam - Link 2008 (po)",
        "DDI Control - Midazolam - Link 2008 (iv)"
      ]
    },
    {
      "Name": "Phimmasone 2001",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
        "DDI Control - Midazolam - Phimmasone 2001"
      ]
    },
    {
      "Name": "Reitman 2011",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Reitman 2011"
      ]
    },
    {
      "Name": "Szalat 2007",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
        "DDI Control - Midazolam - Szalat 2007"
      ]
    },
    {
      "Name": "Kharasch 2011",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
        "DDI Control - Midazolam - Kharasch 2011 (iv)",
        "DDI Control - Midazolam - Kharasch 2011 (po)"
      ]
    },
    {
      "Name": "Kharasch 1997",
      "Classifiables": [
        "DDI Control - Midazolam - Kharasch 1997",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
      ]
    }
  ]
}